JENNIFER S. BUELL, PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Protagenic Therapeutics, Inc.\new

Filing Date Source Excerpt
2023-11-02 Jennifer S. Buell, Ph.D., Director, joined us on July 18, 2020... Dr. Buell serves as the President and Chief Operating Officer of Agenus Inc.... Dr. Buell obtained her PhD in Cellular, Biochemical, and Molecular Biochemistry... The Science Committee consists of Jennifer S. Buell, Ph.D., Garo H. Armen, Ph.D. and Robert B. Stein, MD, Ph.D. (Chair). The Clinical and Regulatory Committee consists of Jennifer S. Buell, Ph.D. (Chair), Garo H. Armen, Ph.D. and Robert B. Stein, MD, Ph.D.
2025-01-03 Jennifer S. Buell, Ph.D., Director, joined us on July 18, 2020, filling the open board seat created when our Board approved the increase of the size of our Board from five to six directors. ... The Science Committee consists of Jennifer S. Buell, Ph.D., Garo H. Armen, Ph.D. and Robert B. Stein, MD, Ph.D. (Chair). ... The Clinical and Regulatory Committee consists of Jennifer S. Buell, Ph.D. (Chair), Garo H. Armen, Ph.D. and Robert B. Stein, MD, Ph.D.

Data sourced from SEC filings. Last updated: 2026-03-05